Praxis Precision Medicines (PRAX) Cash from Operations (QoQ) (2020 - 2026)

Praxis Precision Medicines (PRAX) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Praxis Precision Medicines 9.37 Bn 8.58 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.88%
Dec 31, 2025 -17.32%
Sep 30, 2025 -18.99%
Jun 30, 2025 -3.14%
Mar 31, 2025 5.55%
Dec 31, 2024 -104.08%
Sep 30, 2024 -0.81%
Jun 30, 2024 -30.79%
Mar 31, 2024 12.59%
Dec 31, 2023 -2.78%
Sep 30, 2023 25.63%
Jun 30, 2023 4.97%
Mar 31, 2023 -14.02%
Dec 31, 2022 35.87%
Sep 30, 2022 21.48%
Jun 30, 2022 -5.73%
Mar 31, 2022 -20.63%
Dec 31, 2021 -87.20%
Sep 30, 2021 20.16%
Jun 30, 2021 -16.68%